Serina Therapeutics, Inc. SEC filings SER

Serina Therapeutics, Inc. has 519 filings in SEC EDGAR's recent list, going back to Jul 10, 2017. Its latest annual report, Form 10-K, was filed on Mar 25, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 9, 2026 (bylaw or fiscal year change). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K/A Amended annual report Mar 27, 2026 Dec 31, 2025
10-K Annual report Mar 25, 2026 Dec 31, 2025
10-K Annual report Mar 24, 2025 Dec 31, 2024
ARS Annual report to shareholders Nov 6, 2024 Dec 31, 2023
10-K Annual report Mar 22, 2024 Dec 31, 2023
10-K Annual report Mar 31, 2023 Dec 31, 2022
10-K Annual report Mar 29, 2022 Dec 31, 2021
10-K Annual report Mar 31, 2021 Dec 31, 2020
10-K/A Amended annual report May 22, 2020 Dec 31, 2019
10-K/A Amended annual report Mar 31, 2020 Dec 31, 2019
10-K Annual report Mar 30, 2020 Dec 31, 2019
10-K/A Amended annual report Apr 30, 2019 Dec 31, 2018
10-K Annual report Apr 1, 2019 Dec 31, 2018

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
SER (NYSE)
Fiscal year ends
December 31
Incorporated in
AL
Headquarters
Huntsville, AL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1708599
Former names
AgeX Therapeutics, Inc. (until Apr 1, 2024)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.